Piceatannol enhances Beclin-1 activity to suppress tumor progression and its combination therapy strategy with everolimus in gastric cancer

Longtao Huangfu(Peking University), Jiafu Ji(Peking University), Qian Yao(Beijing Tongren Hospital), Xiaofang Xing(Peking University), Gangjian Wang(Peking University), Shanshan Tian(Capital Medical University), Xiaoyang Wang(Third Affiliated Hospital of Zhengzhou University), Yuqin Wang(Fujian Medical University), Cong Chen(Fujian University of Traditional Chinese Medicine), Biao Fan(Peking University), Jing Han(Hebei Medical University), Junbing Chen(Fudan University)
Science China Life Sciences
October 20, 2022
10.1007/s11427-022-2185-9
Cited by 25

Related Papers

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
Synergistic Activation of Caspase-3 by m-Calpain after Neonatal Hypoxia-Ischemia
|Journal of Biological Chemistry|2001|441
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
|癌症：英文版|2023|412
The influence of age on apoptotic and other mechanisms of cell death after cerebral hypoxia–ischemia
|Cell Death and Differentiation|2004|396